Anatomy of a Physician Prosecution
How does the federal government get members of a grand jury to indict an innocent doctor? It turns out to ...
Biden’s Stance on Medical Costs and Abortion
President Biden highlighted key points on health policy during his State of the Union address. His comments impact health policy ...
Closing the Health Startup Divide
The digital transformation strategists tell us that it requires cultural change, process improvement, technology, and workforce upskilling.
A Patient’s Plea for Justice
Kristen Ogden is a chronic pain patient advocate who has led the charge to protect her physician, Dr. Bockoff.
California Likely Fined $40M for Lapses in Prison Suicide Prevention
California could face more than $40 million in fines after it failed to improve suicide prevention measures in state prisons.
Abortion’s the Tiebreaker
Abortion might not be the main issue for voters, but it will be the issue that decides the swing states, ...
Legalities of Prison Healthcare
Healthcare in prison is notoriously lacking and clinical outcomes for those incarcerated are far worse than the national average.
Medical Crimes Against Humanity
By all accounts Dr. Bockoff was a kind and caring physician dedicated to improving the lives of his patients. Why ...
The Wolf That Killed Me as a Child
It has been more than 20 years since the start of these wars. Twenty years of silence. Twenty years of ...
Who Knows How to Spend Opioid Settlement Cash?
Addiction medicine doctor Stephen Loyd announced what he called “a game-changer” for state and local governments.
Execution of a Bad Man
To ensure the safety of the citizens of this great country, if there is any chance that a “bad man” ...
PT Water Therapy
Water therapy may seem like an unconventional choice for PT to some, but the benefits it provides are undeniable.
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more